SBIR-STTR Award

Use of electrical signals for breast cancer screening
Award last edited on: 3/21/2002

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Mark L Faupel

Company Information

MacKay Life Sciences Inc (AKA: Biofield Corporation)

1025 Nine North Drive Suite M
Alpharetta, GA 30076
   (770) 740-8180
   N/A
   www.biofield.com
Location: Single
Congr. District: 06
County: Fulton

Phase I

Contract Number: 1R43CA050829-01A2
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1992
Phase I Amount
$50,000
We intend to develop and test a non-invasive, cost-effective method for breast cancer screening. The technology involves the scanning of electrical signals from the breast surface. The specific aims are to develop the hardware and software for such an application and to test the method on representative groups of the breast patient population. If the feasibility of this method can be demonstrated during Phase I, we will demonstrate efficacy under a more comprehensive breast screening protocol in Phase II.Awardee's statement of the potential commercial applications of the research:This technology has the potential to provide a non-invasive, cost-effective means of breast cancer screening. The device would be less expensive than mammography equipment, and would be affordable by the office-based physician. The test could become part of a routine checkup in the primary care office.National Cancer Institute (NCI)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----